A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients.

Li, Fangyuan; Ye, Pucong; Hao, Yu; Du, Juan; Zhang, Hang; Wang, Zengtao; Wang, Xumin; Zeng, Hui; Ma, Yaluan; Lin, Jie

Li, Fangyuan; Ye, Pucong; Hao, Yu; Du, Juan; Zhang, Hang; Wang, Zengtao; Wang, Xumin; Zeng, Hui; Ma, Yaluan; Lin, Jie.

Afiliação

Li F; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Peking University Ditan Teaching Hospital, Beijing, China.
Ye P; Department of Critical Care Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Hao Y; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Du J; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zhang H; Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Wang Z; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Wang X; College of Life Sciences, Yantai University, Yantai, China.
Zeng H; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Peking University Ditan Teaching Hospital, Beijing, China.
Ma Y; The Institute of Basic Medical Theory of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Lin J; Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.